Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Knutsson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Medical Virology|November 24, 1999
Urine from chronic hepatitis B virus carriers: implications for infectivityM Knutsson, K Kidd-Ljunggren
Contraception|July 1, 1995
Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive useH Jernstrom, M Knutsson, H Olsson
Contraception|December 1, 1992
Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habitsH Jernström, M Knutsson, P Taskila, et al.
Journal of Molecular Recognition : JMR|March 17, 1999
Novel chiral recognition elements for molecularly imprinted polymer preparationM Knutsson, H S Andersson, I A Nicholls
Intensive & Critical Care Nursing|September 29, 2004
Visits of children to patients being cared for in adult ICUs: policies, guidelines and recommendationsSusanne E M Knutsson, Cecilia L Otterberg, Ingegerd L Bergbom
Diabetes, Obesity & Metabolism|September 7, 2012
Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose studyH Denison, C Nilsson, M Kujacic, et al.
Clinical Science (London, England : 1979)|November 29, 2001
Vasoactive intestinal peptide has a direct positive inotropic effect on isolated human myocardial trabeculaeO Saetrum Opgaard, M Knutsson, R de Vries, et al.
Diabetes, Obesity & Metabolism|July 11, 2012
Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitusL A Morrow, M Leonsson-Zachrisson, H Ericsson, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 6, 1997
On-line supported liquid membrane-liquid chromatography with a phenol oxidase-based biosensor as a selective detection unit for the determination of phenols in blood plasmaJ Norberg, J A Emnéus, J A Jönsson, et al.
Journal of Clinical Microbiology|September 2, 2000
Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strainsE Flodgren, S Bengtsson, M Knutsson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Medical Virology|November 24, 1999
Urine from chronic hepatitis B virus carriers: implications for infectivityM Knutsson, K Kidd-Ljunggren
Contraception|July 1, 1995
Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive useH Jernstrom, M Knutsson, H Olsson
Contraception|December 1, 1992
Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habitsH Jernström, M Knutsson, P Taskila, et al.
Journal of Molecular Recognition : JMR|March 17, 1999
Novel chiral recognition elements for molecularly imprinted polymer preparationM Knutsson, H S Andersson, I A Nicholls
Intensive & Critical Care Nursing|September 29, 2004
Visits of children to patients being cared for in adult ICUs: policies, guidelines and recommendationsSusanne E M Knutsson, Cecilia L Otterberg, Ingegerd L Bergbom
Diabetes, Obesity & Metabolism|September 7, 2012
Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose studyH Denison, C Nilsson, M Kujacic, et al.
Clinical Science (London, England : 1979)|November 29, 2001
Vasoactive intestinal peptide has a direct positive inotropic effect on isolated human myocardial trabeculaeO Saetrum Opgaard, M Knutsson, R de Vries, et al.
Diabetes, Obesity & Metabolism|July 11, 2012
Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitusL A Morrow, M Leonsson-Zachrisson, H Ericsson, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 6, 1997
On-line supported liquid membrane-liquid chromatography with a phenol oxidase-based biosensor as a selective detection unit for the determination of phenols in blood plasmaJ Norberg, J A Emnéus, J A Jönsson, et al.
Journal of Clinical Microbiology|September 2, 2000
Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strainsE Flodgren, S Bengtsson, M Knutsson, et al.
Pageof 2